Clinical Trial Update: Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p> [Phase 2]

View source ↗

Summary

This update covers a Phase 2 clinical trial evaluating filgrastim-treated donor peripheral stem cell transplantation for acute leukemia, and notes the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED